Janssen Issuing Refunds for 340B Overcharges

Janssen
Janssen Biotech is paying refunds for overcharges on certain 340B drugs purchased in the third quarter of 2020.
Drug manufacturer Janssen Biotech recently determined that it owes or may owe refunds to some 340B covered entities. The refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Allows Immediate 340B Enrollment in Florida Due to Hurricane

HRSA updated 340B enrollment eligibility guidelines in Florida in response to a public health emergency for Hurricane Idalia.
Eligible covered entities in Florida may enroll in the 340B program immediately rather than having to wait for the next [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Heather Erickson, 340B Consultant, CPS Solutions

Heather Erickson headshot
Heather Erickson

Q: Where did you grow up?

Growing up, I was a bit backwards and spent my winters in Minnesota and my summers in Florida. In adulthood, though, I realized that was silly and flipped the script – now I spend winters in Florida and summers in Minnesota!

Q: Where did you go to college?

I went to Saint

Read More »

Expert Tip From Maxor

img
img

TIP: Be prepared to answer 340B claims eligibility questions in an audit.


Covered entities need to be

Read More »

As CMS Extends Comment Period on 340B Repayments, Hospitals Urge Changes

CMS headquarters
CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.
While federal regulators recently extended the comment period on a proposed lump sum repayment plan for hospitals Illegally underpaid for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Provider Groups Oppose 340B Provisions in Committee Chair’s Drug Shortage Bill

House E&C wordmark
Provider groups criticized draft legislation to address drug shortages from the House Energy and Commerce Committee.
Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Strengthening 340B Program Integrity to Improve Accountability and Confidence

SPONSORED CONTENT

An update on new reporting requirements and the continuous program compliance imperative

The integrity of the 340B drug discount program is under a microscope. Two states have recently passed laws requiring 340B

Read More »

PhRMA to Federal Appeals Court: Arkansas Enforcing 340B Contract Pharmacy Law; Seventh Drugmaker Sues Over IRA

Eighth Circuit Court
PhRMA filed a citation to notify the U.S. Eighth Circuit Court of Appeals in St. Louis that Arkansas is enforcing its 340B contract pharmacy law.
The drug industry group challenging the legality of Arkansas’ 340B contract pharmacy law, notified a federal appeals court that the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tolmar Providing Refunds for Five Years of 340B Overcharges

Drugmaker Tolmar said it will refund 340B covered entities for overcharges on certain generic dermatologic products.
Drug manufacturer Tolmar recently said it plans refunds to 340B covered entities for overcharges on seven generic dermatologic products purchased [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Value Pillars for 340B Program Compliance

Craig Frost headshot

SPONSORED CONTENT

For 340B program directors, complying with the U.S. Health Resources & Services Administration’s (HRSA’s) requirements is top of mind, all the time. That’s partly because maintaining their employer’s 340B program directly ties to profitability and sometimes survival.  Covered entities need

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live